Skip Navigation

European Heart Journal 1999 20(24):1761-1763; doi:10.1053/euhj.1999.1903
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fagerberg, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagerberg, B
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

The merit of beta1-blockade in heart failure

B Fagerberg

Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden

References

  1. Chidsey CA, Braunwald E, Morrow AG. Catecholamine secretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med. 1965;39:442–451[CrossRef][ISI][Medline]
  2. Waagstein F, Hjalmarson , Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022–1036[Abstract/Free Full Text]
  3. Lancet. 1999;353:2001–2007[CrossRef][ISI][Medline]
  4. Andersson B, berg J. The effect on heart rate of immediate and slow-release metoprolol in patients with chronic heart failure (Abstract). J Am Coll Cardiol. 1999;33:183A–184A
  5. Lancet. 1999;353:9–13[CrossRef][ISI][Medline]
  6. Garg RG, Yusuf S. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–1456[Abstract/Free Full Text]
  7. Cleland JGF, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J. 1996;17:1629–1639[Free Full Text]
  8. N Engl J Med. 1991;325:293–302[Abstract]
  9. Pfeffer MA, Braunwald E, Moyé LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669–677[Abstract]
  10. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. Eur Heart J. 1997;18:560–565[Abstract/Free Full Text]
  11. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355[Abstract/Free Full Text]
  12. Lancet. 1997;349:375–380[CrossRef][ISI][Medline]
  13. Sharpe NM, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet. 1998;352:3–7[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fagerberg, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagerberg, B
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?